 | • レポートコード：MRC2102QY7031 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、130ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界の不活化ワクチン市場について種類別（子供、大人）、用途別（病院、医療センター）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・不活化ワクチン市場の概要 ・世界の主要地域別不活化ワクチン市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の不活化ワクチン市場規模2015-2026：種類別（子供、大人） ・世界の不活化ワクチン市場規模2015-2026：用途別（病院、医療センター） ・不活化ワクチンの米国市場規模2015-2020 ・不活化ワクチンのヨーロッパ市場規模2015-2020 ・不活化ワクチンの中国市場規模2015-2020 ・不活化ワクチンの日本市場規模2015-2020 ・不活化ワクチンの東南アジア市場規模2015-2020 ・不活化ワクチンのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・不活化ワクチンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・不活化ワクチンの市場動向・機会・課題 ・調査の結論 |
Inactivated vaccines are viruses or bacteria that are first cultured and then inactivated with heat or chemicals. Inactivated vaccines may consist of whole viruses or bacteria, or they may consist of fragments that cleave together to form a cleaved vaccine.
Market Analysis and Insights: Global Inactivated Vaccine Market
The global Inactivated Vaccine market size is projected to reach US$ 7303 million by 2026, from US$ 5994.6 million in 2020, at a CAGR of 3.3% during 2021-2026.
Global Inactivated Vaccine Scope and Market Size
The global Inactivated Vaccine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Inactivated Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Inactivated Vaccine market is segmented into
Children
Adult
Segment by Application, the Inactivated Vaccine market is segmented into
Hospital
Medical Center
The Inactivated Vaccine market is analysed and market size information is provided by regions (countries). Segment by Application, the Inactivated Vaccine market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Inactivated Vaccine Market Share Analysis
Inactivated Vaccine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Inactivated Vaccine business, the date to enter into the Inactivated Vaccine market, Inactivated Vaccine product introduction, recent developments, etc.
The major vendors covered:
Astellas Pharma (Japan)
CSL Limited (Australia)
Emergent BioSolutions (U.S.)
GlaxoSmithKline (U.K.)
Johnson & Johnson (U.S.)
MedImmune (U.S.)
Merck & Co (U.S.)
Pfizer (U.S.)
Sanofi Pasteur (France)
Serum Institute of India Pvt (India)
1 Inactivated Vaccine Market Overview
1.1 Inactivated Vaccine Product Scope
1.2 Inactivated Vaccine Segment by Type
1.2.1 Global Inactivated Vaccine Sales by Type (2020-2026)
1.2.2 Children
1.2.3 Adult
1.3 Inactivated Vaccine Segment by Application
1.3.1 Global Inactivated Vaccine Sales Comparison by Application (2020-2026)
1.3.2 Hospital
1.3.3 Medical Center
1.4 Inactivated Vaccine Market Estimates and Forecasts (2015-2026)
1.4.1 Global Inactivated Vaccine Sales Growth Rate (2015-2026)
1.4.2 Global Inactivated Vaccine Revenue and Growth Rate (2015-2026)
1.4.3 Global Inactivated Vaccine Price Trends (2015-2026)
2 Inactivated Vaccine Estimate and Forecast by Region
2.1 Global Inactivated Vaccine Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Inactivated Vaccine Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Inactivated Vaccine Sales Market Share by Region (2015-2020)
2.2.2 Global Inactivated Vaccine Revenue Market Share by Region (2015-2020)
2.3 Global Inactivated Vaccine Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Inactivated Vaccine Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Inactivated Vaccine Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Inactivated Vaccine Estimates and Projections (2015-2026)
2.4.2 Europe Inactivated Vaccine Estimates and Projections (2015-2026)
2.4.3 China Inactivated Vaccine Estimates and Projections (2015-2026)
2.4.4 Japan Inactivated Vaccine Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Inactivated Vaccine Estimates and Projections (2015-2026)
2.4.6 India Inactivated Vaccine Estimates and Projections (2015-2026)
3 Global Inactivated Vaccine Competition Landscape by Players
3.1 Global Top Inactivated Vaccine Players by Sales (2015-2020)
3.2 Global Top Inactivated Vaccine Players by Revenue (2015-2020)
3.3 Global Inactivated Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Inactivated Vaccine as of 2019)
3.4 Global Inactivated Vaccine Average Price by Company (2015-2020)
3.5 Manufacturers Inactivated Vaccine Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Inactivated Vaccine Players (Opinion Leaders)
4 Global Inactivated Vaccine Market Size by Type
4.1 Global Inactivated Vaccine Historic Market Review by Type (2015-2020)
4.1.1 Global Inactivated Vaccine Sales Market Share by Type (2015-2020)
4.1.2 Global Inactivated Vaccine Revenue Market Share by Type (2015-2020)
4.1.3 Global Inactivated Vaccine Price by Type (2015-2020)
4.2 Global Inactivated Vaccine Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Inactivated Vaccine Sales Forecast by Type (2021-2026)
4.2.2 Global Inactivated Vaccine Revenue Forecast by Type (2021-2026)
4.2.3 Global Inactivated Vaccine Price Forecast by Type (2021-2026)
5 Global Inactivated Vaccine Market Size by Application
5.1 Global Inactivated Vaccine Historic Market Review by Application (2015-2020)
5.1.1 Global Inactivated Vaccine Sales Market Share by Application (2015-2020)
5.1.2 Global Inactivated Vaccine Revenue Market Share by Application (2015-2020)
5.1.3 Global Inactivated Vaccine Price by Application (2015-2020)
5.2 Global Inactivated Vaccine Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Inactivated Vaccine Sales Forecast by Application (2021-2026)
5.2.2 Global Inactivated Vaccine Revenue Forecast by Application (2021-2026)
5.2.3 Global Inactivated Vaccine Price Forecast by Application (2021-2026)
6 United States Inactivated Vaccine Market Facts & Figures
6.1 United States Inactivated Vaccine Sales Market Share by Company (2015-2020)
6.2 United States Inactivated Vaccine Sales Market Share by Type (2015-2020)
6.3 United States Inactivated Vaccine Sales Market Share by Application (2015-2020)
7 Europe Inactivated Vaccine Market Facts & Figures
7.1 Europe Inactivated Vaccine Sales Market Share by Company (2015-2020)
7.2 Europe Inactivated Vaccine Sales Market Share by Type (2015-2020)
7.3 Europe Inactivated Vaccine Sales Market Share by Application (2015-2020)
8 China Inactivated Vaccine Market Facts & Figures
8.1 China Inactivated Vaccine Sales Market Share by Company (2015-2020)
8.2 China Inactivated Vaccine Sales Market Share by Type (2015-2020)
8.3 China Inactivated Vaccine Sales Market Share by Application (2015-2020)
9 Japan Inactivated Vaccine Market Facts & Figures
9.1 Japan Inactivated Vaccine Sales Market Share by Company (3015-3030)
9.2 Japan Inactivated Vaccine Sales Market Share by Type (2015-2020)
9.3 Japan Inactivated Vaccine Sales Market Share by Application (2015-2020)
10 Southeast Asia Inactivated Vaccine Market Facts & Figures
10.1 Southeast Asia Inactivated Vaccine Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Inactivated Vaccine Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Inactivated Vaccine Sales Market Share by Application (2015-2020)
11 India Inactivated Vaccine Market Facts & Figures
11.1 India Inactivated Vaccine Sales Market Share by Company (2015-2020)
11.2 India Inactivated Vaccine Sales Market Share by Type (2015-2020)
11.3 India Inactivated Vaccine Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Inactivated Vaccine Business
12.1 Astellas Pharma (Japan)
12.1.1 Astellas Pharma (Japan) Corporation Information
12.1.2 Astellas Pharma (Japan) Business Overview
12.1.3 Astellas Pharma (Japan) Inactivated Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Astellas Pharma (Japan) Inactivated Vaccine Products Offered
12.1.5 Astellas Pharma (Japan) Recent Development
12.2 CSL Limited (Australia)
12.2.1 CSL Limited (Australia) Corporation Information
12.2.2 CSL Limited (Australia) Business Overview
12.2.3 CSL Limited (Australia) Inactivated Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.2.4 CSL Limited (Australia) Inactivated Vaccine Products Offered
12.2.5 CSL Limited (Australia) Recent Development
12.3 Emergent BioSolutions (U.S.)
12.3.1 Emergent BioSolutions (U.S.) Corporation Information
12.3.2 Emergent BioSolutions (U.S.) Business Overview
12.3.3 Emergent BioSolutions (U.S.) Inactivated Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Emergent BioSolutions (U.S.) Inactivated Vaccine Products Offered
12.3.5 Emergent BioSolutions (U.S.) Recent Development
12.4 GlaxoSmithKline (U.K.)
12.4.1 GlaxoSmithKline (U.K.) Corporation Information
12.4.2 GlaxoSmithKline (U.K.) Business Overview
12.4.3 GlaxoSmithKline (U.K.) Inactivated Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.4.4 GlaxoSmithKline (U.K.) Inactivated Vaccine Products Offered
12.4.5 GlaxoSmithKline (U.K.) Recent Development
12.5 Johnson & Johnson (U.S.)
12.5.1 Johnson & Johnson (U.S.) Corporation Information
12.5.2 Johnson & Johnson (U.S.) Business Overview
12.5.3 Johnson & Johnson (U.S.) Inactivated Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Johnson & Johnson (U.S.) Inactivated Vaccine Products Offered
12.5.5 Johnson & Johnson (U.S.) Recent Development
12.6 MedImmune (U.S.)
12.6.1 MedImmune (U.S.) Corporation Information
12.6.2 MedImmune (U.S.) Business Overview
12.6.3 MedImmune (U.S.) Inactivated Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.6.4 MedImmune (U.S.) Inactivated Vaccine Products Offered
12.6.5 MedImmune (U.S.) Recent Development
12.7 Merck & Co (U.S.)
12.7.1 Merck & Co (U.S.) Corporation Information
12.7.2 Merck & Co (U.S.) Business Overview
12.7.3 Merck & Co (U.S.) Inactivated Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Merck & Co (U.S.) Inactivated Vaccine Products Offered
12.7.5 Merck & Co (U.S.) Recent Development
12.8 Pfizer (U.S.)
12.8.1 Pfizer (U.S.) Corporation Information
12.8.2 Pfizer (U.S.) Business Overview
12.8.3 Pfizer (U.S.) Inactivated Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Pfizer (U.S.) Inactivated Vaccine Products Offered
12.8.5 Pfizer (U.S.) Recent Development
12.9 Sanofi Pasteur (France)
12.9.1 Sanofi Pasteur (France) Corporation Information
12.9.2 Sanofi Pasteur (France) Business Overview
12.9.3 Sanofi Pasteur (France) Inactivated Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Sanofi Pasteur (France) Inactivated Vaccine Products Offered
12.9.5 Sanofi Pasteur (France) Recent Development
12.10 Serum Institute of India Pvt (India)
12.10.1 Serum Institute of India Pvt (India) Corporation Information
12.10.2 Serum Institute of India Pvt (India) Business Overview
12.10.3 Serum Institute of India Pvt (India) Inactivated Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Serum Institute of India Pvt (India) Inactivated Vaccine Products Offered
12.10.5 Serum Institute of India Pvt (India) Recent Development
13 Inactivated Vaccine Manufacturing Cost Analysis
13.1 Inactivated Vaccine Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Inactivated Vaccine
13.4 Inactivated Vaccine Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Inactivated Vaccine Distributors List
14.3 Inactivated Vaccine Customers
15 Market Dynamics
15.1 Inactivated Vaccine Market Trends
15.2 Inactivated Vaccine Opportunities and Drivers
15.3 Inactivated Vaccine Market Challenges
15.4 Inactivated Vaccine Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Inactivated Vaccine Sales (MT) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Inactivated Vaccine Sales (MT) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Inactivated Vaccine Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Inactivated Vaccine Sales (MT) by Region (2015-2020)
Table 5. Global Inactivated Vaccine Sales Market Share by Region (2015-2020)
Table 6. Global Inactivated Vaccine Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Inactivated Vaccine Revenue Share by Region (2015-2020)
Table 8. Global Inactivated Vaccine Sales (MT) Forecast by Region (2021-2026)
Table 9. Global Inactivated Vaccine Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Inactivated Vaccine Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Inactivated Vaccine Revenue Share Forecast by Region (2021-2026)
Table 12. Global Inactivated Vaccine (MT) of Key Companies (2015-2020)
Table 13. Global Inactivated Vaccine Sales Share by Company (2015-2020)
Table 14. Global Inactivated Vaccine Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Inactivated Vaccine Revenue Share by Company (2015-2020)
Table 16. Global Inactivated Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Inactivated Vaccine as of 2019)
Table 17. Global Inactivated Vaccine Average Price (USD/MT) of Key Company (2015-2020)
Table 18. Manufacturers Inactivated Vaccine Manufacturing Sites and Area Served
Table 19. Manufacturers Inactivated Vaccine Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Inactivated Vaccine Players
Table 22. Global Inactivated Vaccine Sales (MT) by Type (2015-2020)
Table 23. Global Inactivated Vaccine Sales Share by Type (2015-2020)
Table 24. Global Inactivated Vaccine Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Inactivated Vaccine Price (MT) by Type (2015-2020)
Table 26. Global Inactivated Vaccine Sales Share by Type (2021-2026)
Table 27. Global Inactivated Vaccine Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Inactivated Vaccine Revenue Share by Type (2021-2026)
Table 29. Global Inactivated Vaccine Price (MT) by Type (2021-2026)
Table 30. Global Inactivated Vaccine Sales (MT) by Application (2015-2020)
Table 31. Global Inactivated Vaccine Sales Share by Application (2015-2020)
Table 32. Global Inactivated Vaccine Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Inactivated Vaccine Price (MT) by Application (2015-2020)
Table 34. Global Inactivated Vaccine Sales (MT) by Application (2021-2026)
Table 35. Global Inactivated Vaccine Sales Share by Application (2021-2026)
Table 36. Global Inactivated Vaccine Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Inactivated Vaccine Revenue Share by Application (2021-2026)
Table 38. Global Inactivated Vaccine Price (MT) by Application (2021-2026)
Table 39. United States Inactivated Vaccine Sales (MT) by Company (2015-2020)
Table 40. United States Inactivated Vaccine Sales Market Share by Company (2015-2020)
Table 41. United States Inactivated Vaccine Sales (MT) by Type (2015-2020)
Table 42. United States Inactivated Vaccine Sales Market Share by Type (2015-2020)
Table 43. United States Inactivated Vaccine Sales (MT) by Application (2015-2020)
Table 44. United States Inactivated Vaccine Sales Market Share by Application (2015-2020)
Table 45. Europe Inactivated Vaccine Sales (MT) by Company (2015-2020)
Table 46. Europe Inactivated Vaccine Sales Market Share by Company (2015-2020)
Table 47. Europe Inactivated Vaccine Sales (MT) by Type (2015-2020)
Table 48. Europe Inactivated Vaccine Sales Market Share by Type (2015-2020)
Table 49. Europe Inactivated Vaccine Sales (MT) by Application (2015-2020)
Table 50. Europe Inactivated Vaccine Sales Market Share by Type (2015-2020)
Table 51. China Inactivated Vaccine Sales (MT) by Company (2015-2020)
Table 52. China Inactivated Vaccine Sales Market Share by Company (2015-2020)
Table 53. China Inactivated Vaccine Sales (MT) by Type (2015-2020)
Table 54. China Inactivated Vaccine Sales Market Share by Type (2015-2020)
Table 55. China Inactivated Vaccine Sales (MT) by Application (2015-2020)
Table 56. China Inactivated Vaccine Sales Market Share by Application (2015-2020)
Table 57. Japan Inactivated Vaccine Sales (MT) by Company (2015-2020)
Table 58. Japan Inactivated Vaccine Sales Market Share by Company (2015-2020)
Table 59. Japan Inactivated Vaccine Sales (MT) by Type (2015-2020)
Table 60. Japan Inactivated Vaccine Sales Market Share by Type (2015-2020)
Table 61. Japan Inactivated Vaccine Sales (MT) by Application (2015-2020)
Table 62. Japan Inactivated Vaccine Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Inactivated Vaccine Sales (MT) by Company (2015-2020)
Table 64. Southeast Asia Inactivated Vaccine Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Inactivated Vaccine Sales (MT) by Type (2015-2020)
Table 66. Southeast Asia Inactivated Vaccine Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Inactivated Vaccine Sales (MT) by Type (2015-2020)
Table 68. Southeast Asia Inactivated Vaccine Sales Market Share by Application (2015-2020)
Table 69. India Inactivated Vaccine Sales (MT) by Company (2015-2020)
Table 70. India Inactivated Vaccine Sales Market Share by Company (2015-2020)
Table 71. India Inactivated Vaccine Sales (MT) by Type (2015-2020)
Table 72. India Inactivated Vaccine Sales Market Share by Type (2015-2020)
Table 73. India Inactivated Vaccine Sales (MT) by Application (2015-2020)
Table 74. India Inactivated Vaccine Sales Market Share by Application (2015-2020)
Table 75. Astellas Pharma (Japan) Corporation Information
Table 76. Astellas Pharma (Japan) Description and Business Overview
Table 77. Astellas Pharma (Japan) Inactivated Vaccine Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. Astellas Pharma (Japan) Inactivated Vaccine Product
Table 79. Astellas Pharma (Japan) Recent Development
Table 80. CSL Limited (Australia) Corporation Information
Table 81. CSL Limited (Australia) Description and Business Overview
Table 82. CSL Limited (Australia) Inactivated Vaccine Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. CSL Limited (Australia) Inactivated Vaccine Product
Table 84. CSL Limited (Australia) Recent Development
Table 85. Emergent BioSolutions (U.S.) Corporation Information
Table 86. Emergent BioSolutions (U.S.) Description and Business Overview
Table 87. Emergent BioSolutions (U.S.) Inactivated Vaccine Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Emergent BioSolutions (U.S.) Inactivated Vaccine Product
Table 89. Emergent BioSolutions (U.S.) Recent Development
Table 90. GlaxoSmithKline (U.K.) Corporation Information
Table 91. GlaxoSmithKline (U.K.) Description and Business Overview
Table 92. GlaxoSmithKline (U.K.) Inactivated Vaccine Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. GlaxoSmithKline (U.K.) Inactivated Vaccine Product
Table 94. GlaxoSmithKline (U.K.) Recent Development
Table 95. Johnson & Johnson (U.S.) Corporation Information
Table 96. Johnson & Johnson (U.S.) Description and Business Overview
Table 97. Johnson & Johnson (U.S.) Inactivated Vaccine Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Johnson & Johnson (U.S.) Inactivated Vaccine Product
Table 99. Johnson & Johnson (U.S.) Recent Development
Table 100. MedImmune (U.S.) Corporation Information
Table 101. MedImmune (U.S.) Description and Business Overview
Table 102. MedImmune (U.S.) Inactivated Vaccine Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. MedImmune (U.S.) Inactivated Vaccine Product
Table 104. MedImmune (U.S.) Recent Development
Table 105. Merck & Co (U.S.) Corporation Information
Table 106. Merck & Co (U.S.) Description and Business Overview
Table 107. Merck & Co (U.S.) Inactivated Vaccine Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. Merck & Co (U.S.) Inactivated Vaccine Product
Table 109. Merck & Co (U.S.) Recent Development
Table 110. Pfizer (U.S.) Corporation Information
Table 111. Pfizer (U.S.) Inactivated Vaccine Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. Pfizer (U.S.) Description and Business Overview
Table 113. Pfizer (U.S.) Inactivated Vaccine Product
Table 114. Pfizer (U.S.) Recent Development
Table 115. Sanofi Pasteur (France) Corporation Information
Table 116. Sanofi Pasteur (France) Inactivated Vaccine Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. Sanofi Pasteur (France) Description and Business Overview
Table 118. Sanofi Pasteur (France) Inactivated Vaccine Product
Table 119. Sanofi Pasteur (France) Recent Development
Table 120. Serum Institute of India Pvt (India) Corporation Information
Table 121. Serum Institute of India Pvt (India) Description and Business Overview
Table 122. Serum Institute of India Pvt (India) Inactivated Vaccine Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 123. Serum Institute of India Pvt (India) Inactivated Vaccine Product
Table 124. Serum Institute of India Pvt (India) Recent Development
Table 125. Production Base and Market Concentration Rate of Raw Material
Table 126. Key Suppliers of Raw Materials
Table 127. Inactivated Vaccine Distributors List
Table 128. Inactivated Vaccine Customers List
Table 129. Inactivated Vaccine Market Key Trends
Table 130. Inactivated Vaccine Key Opportunities and Drivers
Table 131. Inactivated Vaccine Market Challenges
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Inactivated Vaccine Product Picture
Figure 2. Global Inactivated Vaccine Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Inactivated Vaccine Market Share by Application in 2020 & 2026
Figure 6. Hospital Examples
Figure 7. Medical Center Examples
Figure 8. Global Inactivated Vaccine Sales (MT) Growth Rate (2015-2026)
Figure 9. Global Inactivated Vaccine Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Inactivated Vaccine Price Trends Growth Rate (2015-2026) (USD/MT)
Figure 11. Global Inactivated Vaccine Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Inactivated Vaccine Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Inactivated Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Inactivated Vaccine Sales (MT) Growth Rate (2015-2026)
Figure 15. Europe Inactivated Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Inactivated Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Inactivated Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Inactivated Vaccine Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Inactivated Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Inactivated Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Inactivated Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Inactivated Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Inactivated Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Inactivated Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Inactivated Vaccine Players Market Share by Revenue in Inactivated Vaccine 2015 & 2019
Figure 26. Inactivated Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Inactivated Vaccine Revenue Share by Type (2015-2020)
Figure 28. Global Inactivated Vaccine Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Inactivated Vaccine Revenue Share by Application (2015-2020)
Figure 30. Global Inactivated Vaccine Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Inactivated Vaccine Sales Market Share by Type in 2019
Figure 32. United States Inactivated Vaccine Sales Market Share by Type in 2019
Figure 33. Europe Inactivated Vaccine Sales Market Share by Company in 2019
Figure 34. Europe Inactivated Vaccine Sales Market Share by Type in 2019
Figure 35. Europe Inactivated Vaccine Sales Market Share by Application in 2019
Figure 36. China Inactivated Vaccine Sales Market Share by Company in 2019
Figure 37. China Inactivated Vaccine Sales Market Share by Type in 2019
Figure 38. China Inactivated Vaccine Sales Market Share by Application in 2019
Figure 39. Japan Inactivated Vaccine Sales Market Share by Company in 2019
Figure 40. Japan Inactivated Vaccine Sales Market Share by Type in 2019
Figure 41. Japan Inactivated Vaccine Sales Market Share by Application in 2019
Figure 42. Southeast Asia Inactivated Vaccine Sales Market Share by Company in 2019
Figure 43. Southeast Asia Inactivated Vaccine Sales Market Share by Type in 2019
Figure 44. Southeast Asia Inactivated Vaccine Sales Market Share by Application in 2019
Figure 45. India Inactivated Vaccine Sales Market Share by Company in 2019
Figure 46. India Inactivated Vaccine Sales Market Share by Type in 2019
Figure 47. India Inactivated Vaccine Sales Market Share by Application in 2019
Figure 48. Key Raw Materials Price Trend
Figure 49. Manufacturing Cost Structure of Inactivated Vaccine
Figure 50. Manufacturing Process Analysis of Inactivated Vaccine
Figure 51. Inactivated Vaccine Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Porter's Five Forces Analysis
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
麻疹（はしか）ワクチンの世界市場レポート2020 Measles vaccine is made by inoculation of attenuated strain of measles virus into chicken embryo cells, culture and harvesting of virus venom, and then freeze-drying. Injection into the lateral deltoid muscle attachment of the upper arm can prevent measles. Market Analysis and Insights: Global Measl…- ヒト用予防ワクチンの世界市場レポート2020 Vaccination in the body of a healthy person causes the person to produce antibodies and obtain specific immunity in the absence of disease. For example, BCG vaccination, smallpox vaccination and so on. Market Analysis and Insights: Global Prophylactic Human Vaccine Market The global Prophylactic Hum…
- 点鼻ワクチンの世界市場レポート2020 Nasal Spray Vaccine refers to a vaccine injected through the nose, which is mostly used for influenza. The FluMist is the only alternative to the flu shot without a needle and is given in the form of a nasal spray. Nasal Spray Vaccine is widely sales for Child and Adult The most proportion of Nasal …
- インフルエンザワクチンの世界市場レポート2020 Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 6…
- 23価肺炎球菌多糖体ワクチンの世界市場レポート2020 23-Valent Pneumococcal Polysaccharide Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria. 23-Valent Pneumococcal Polysaccharide Vaccine contains 23 of the most common types of pneumococcal bacteria. 23-Valent Pneumococcal Polysaccharide Vaccine is for use only in …